Eton Pharmaceuticals (ETON) Inventory Average (2020 - 2026)
Eton Pharmaceuticals' (ETON) quarterly Inventory Average came in at $12.8 million in Q2 2026, down 31.67% year-over-year from $18.7 million in Q2 2025, and down 20.8% quarter-over-quarter from $16.1 million in Q4 2025.
Analysis
Eton Pharmaceuticals (ETON) Inventory Average (2020 - 2026) Analysis & Trends
Eton Pharmaceuticals has disclosed Inventory Average across 7 years of filings, most recently posting $12.8 million for Q2 2026.
- In Q2 2026, Inventory Average fell 31.67% year-over-year to $12.8 million; the TTM figure through Jun 2026 stood at $12.8 million (down 31.67% YoY), while the FY2025 annual figure was $15.3 million, up 89.87% from the prior year.
- Inventory Average came in at $12.8 million for Q2 2026 at Eton Pharmaceuticals, down from $16.1 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $20.3 million in Q3 2025 to a low of $497000.0 in Q1 2023.
- Average Inventory Average over 5 years is $6.0 million, with a median of $1.6 million recorded in 2024.
- Year-over-year, Inventory Average sank 59.81% in 2022 and soared 914.63% in 2025.
- Over 5 years, Inventory Average stood at $519000.0 in 2022, then surged by 89.02% to $981000.0 in 2023, then soared by 775.13% to $8.6 million in 2024, then jumped by 87.97% to $16.1 million in 2025, then decreased by 20.8% to $12.8 million in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $12.8 million in Q2 2026, $16.1 million in Q4 2025, and $20.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | 12.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.78 Mn |
| Dec 31, 2025 | 16.14 Mn |
| Sep 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 18.71 Mn |
| Mar 31, 2025 | 14.43 Mn |
| Dec 31, 2024 | 8.59 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 981,000.00 |
| Sep 30, 2023 | 933,500.00 |
| Jun 30, 2023 | 626,500.00 |
| Mar 31, 2023 | 497,000.00 |
| Dec 31, 2022 | 519,000.00 |
| Sep 30, 2022 | 506,000.00 |
| Jun 30, 2022 | 520,500.00 |
| Mar 31, 2022 | 530,000.00 |
| Dec 31, 2021 | 442,000.00 |
| Sep 30, 2021 | 788,000.00 |
| Jun 30, 2021 | 1.30 Mn |